Jin Li, Meijun Li, Liren Li, Lin Ma, Ailin Cao, Aiping Wen, . . . Jianxiong Deng. (2022). Real-world safety of ulinastatin: A post-marketing surveillance of 11,252 patients in China. BMC.
Chicago Style (17th ed.) CitationJin Li, et al. Real-world Safety of Ulinastatin: A Post-marketing Surveillance of 11,252 Patients in China. BMC, 2022.
MLA (9th ed.) CitationJin Li, et al. Real-world Safety of Ulinastatin: A Post-marketing Surveillance of 11,252 Patients in China. BMC, 2022.
Warning: These citations may not always be 100% accurate.